Notice Number: NOT-HG-20-027
Key Dates
Release Date: March 13, 2020
Issued by
National Human Genome Research Institute (NHGRI)
Purpose
The purpose of this Notice is to inform potential applicants that the National Human Genome Research Institute (NHGRI) is participating inPAR-20-041 Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed).
The following sections have been updated to reflect the participation of NHGRI in this FOA:
Part 1. Overview Information
Components of Participating Organizations
National Institute of General Medical Sciences (NIGMS))
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Human Genome Research Institute (NHGRI)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.859; 93.866; 93.853; 93.855; 93.847; 93.121; 93.173, 93.113, 93.233, 93.837, 93.838, 93.839, 93.840;93.279; 93.172.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Luis A. Cubano, Ph.D.
National Human Genome Research Institute
Phone: 301-480-3435
Email: [email protected]
Financial/Grants Management Contact(s)
Deanna Ingersoll
Phone: 301-435-7858
Email: [email protected]
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Luis A. Cubano, Ph.D.
National Human Genome Research Institute
Phone: 301-480-3435
Email: [email protected]